A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns.
暂无分享,去创建一个
B. Elewski | M. Ghannoum | R. Summerbell | N. Konnikov | R. Hajjeh | M. Zaiac | N. Isham | Aditya K. Gupta | A. Gupta | D. Pariser | R. Aly | R A Hajjeh | J. Lesher | P Fleckman | G Rebell | P. Fleckman | M A Ghannoum | A K Gupta | D Pariser | R Scher | N Konnikov | R Summerbell | S Sullivan | R Daniel | P Krusinski | P Rich | R Odom | R Aly | M Zaiac | J Lesher | B Gerlach | G F Ponce-De-Leon | A Ghannoum | J Warner | N Isham | B Elewski | R. Scher | P. Rich | G. Rebell | R. Odom | A. Ghannoum | B. Elewski | S. Sullivan | P. Krusinski | G. Ponce-de-Leon | J. Warner | R. Daniel | B. Gerlach | R. Scher | Jane Warner | R. K. Scher
[1] S. Stubb,et al. The prevalence of onychomycosis in Finland , 1995, The British journal of dermatology.
[2] R. Summerbell,et al. Prevalence and epidemiology of unsuspected onychomycosis in patients visiting dermatologists' offices in Ontario, Canada ‐ a multicenter survey of 2001 patients , 1997, International journal of dermatology.
[3] D. Roberts,et al. Prevalence of dermatophyte onychomycosis in the United Kingdom: Results of an omnibus survey , 1992, The British journal of dermatology.
[4] M. Ghannoum,et al. Antifungal Susceptibility Testing of Dermatophytes: Establishing a Medium for Inducing Conidial Growth and Evaluation of Susceptibility of Clinical Isolates , 2000, Journal of Clinical Microbiology.
[5] M. Pfaller,et al. High frequency of yeast carriage on hands of hospital personnel , 1994, Journal of clinical microbiology.
[6] S. Foley,et al. An epidemic of infection with Trichophyton tonsurans revealed in a 20-year survey of fungal infections in Chicago. , 1983, Journal of the American Academy of Dermatology.
[7] E. Haneke. Epidemiology and Pathology of Onychomycoses , 1990 .
[8] M. Ghannoum,et al. Optimal growth conditions for the determination of the antifungal susceptibility of three species of dermatophytes with the use of a microdilution method. , 1999, Journal of the American Academy of Dermatology.
[9] L. Millérioux,et al. Levels of terbinafine in plasma, stratum corneum, dermis–epidermis (without stratum corneum), sebum, hair and nails during and after 250 mg terbinafine orally once daily for 7 and 14 days , 1994, Clinical and experimental dermatology.
[10] B. Elewski,et al. Prevalence of onychomycosis in patients attending a dermatology clinic in northeastern Ohio for other conditions. , 1997, Archives of dermatology.
[11] J. Peyri,et al. Prevalence of dermatophyte onychomycosis in Spain: a cross‐sectional study , 1995, The British journal of dermatology.
[12] H. C. Williams,et al. The epidemiology of onychomycosis in Britain , 1993, The British journal of dermatology.
[13] Prevalence, morbidity, and cost of dermatological diseases. , 1979, The Journal of investigative dermatology.
[14] I. Cojocaru,et al. A short review on tinea pedis by dermatophytes , 1973, Mykosen.
[15] J. Marley,et al. Non‐dermatophytes in onychomycosis of the toenails , 1997, The British journal of dermatology.
[16] V. Shah,et al. Griseofulvin levels in stratum corneum. Study after oral administration in man. , 1972, Archives of dermatology.